When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about AZZ (AZZ) .AZZ currently has an average brokerage recommendation (ABR) of 1.50, on a scale of 1 ...

Group 1 - BioCryst Pharmaceuticals (BCRX) closed at $10.59, with a 26.2% gain over the past four weeks, and a mean price target of $16.50 indicating a 55.8% upside potential [1] - The average of 12 short-term price targets ranges from a low of $11 to a high of $30, with a standard deviation of $5.32, suggesting variability in analyst estimates [2] - Analysts show strong agreement on BCRX's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 366.9% over the past month, with six estimates revised higher and no negative revisions [12] - BCRX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting stock gains, they can indicate potential price movement direction [13]

Summit Therapeutics PLC (SMMT) closed the last trading session at $25.85, gaining 10.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $37.38 indicates a 44.6% upside potential.The average comprises eight short-term price targets ranging from a low of $30 to a high of $44, with a standard deviation of $5.71. While the lowest estimate indicates an increase of 16.1% from the current ...

Shares of Roku (ROKU) have gained 5% over the past four weeks to close the last trading session at $69.01, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $88.87 indicates a potential upside of 28.8%.The mean estimate comprises 26 short-term price targets with a standard deviation of $17.78. While the lowest estimate of $60 indicates a 13.1% decline from the current price level, ...

Core Viewpoint - Adeia (ADEA) shows potential for significant upside, with a mean price target of $17.33 indicating a 37% increase from its current price of $12.65 [1] Price Targets and Analyst Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $0.58, suggesting a consensus among analysts [2] - The lowest estimate of $17 indicates a 34.4% increase, while the highest estimate suggests a 42.3% increase to $18 [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism about ADEA's earnings prospects, with a positive trend in earnings estimate revisions [11] - Over the last 30 days, one estimate has increased, leading to a 1% rise in the Zacks Consensus Estimate [12] - ADEA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after, they can mislead investors, as empirical research shows they rarely indicate actual price movements [7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8] - Investors should treat price targets with skepticism and not rely solely on them for investment decisions [10]

Group 1 - Consensus Cloud Solutions, Inc. (CCSI) closed at $21.37, with a 10.2% gain over the past four weeks, and a mean price target of $27.40 indicating a 28.2% upside potential [1] - The average price targets range from a low of $20 to a high of $37, with a standard deviation of $7.06, suggesting variability in analyst estimates [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 0.4% over the past month, with two estimates going higher and no negative revisions [12] - CCSI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of potential gains, the implied direction of price movement appears to be a good guide [13]

Copa Holdings (CPA) closed the last trading session at $106.47, gaining 17.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $152.73 indicates a 43.5% upside potential.The average comprises 11 short-term price targets ranging from a low of $125 to a high of $190, with a standard deviation of $19.78. While the lowest estimate indicates an increase of 17.4% from the current price le ...

Core Viewpoint - Priority Technology (PRTH) shows potential for significant upside, with a mean price target of $12.80 indicating a 67.1% increase from the current price of $7.66 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $2.77, indicating variability among analysts [2] - The lowest estimate of $10 suggests a 30.6% increase, while the highest estimate predicts a surge of 108.9% to $16 [2] - Analysts' price targets can often mislead investors, as empirical research shows they rarely indicate actual stock price movements [7][10] Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism regarding PRTH's earnings prospects, with a strong consensus in revising EPS estimates higher [11] - The Zacks Consensus Estimate for the current year has risen by 1.9% over the past month, with one estimate increasing and no negative revisions [12] - PRTH holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13]

Braze, Inc. (BRZE) closed the last trading session at $34.73, gaining 11.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $50.16 indicates a 44.4% upside potential.The mean estimate comprises 19 short-term price targets with a standard deviation of $9.15. While the lowest estimate of $38 indicates a 9.4% increase from the current price level, the most optimistic analyst expects t ...

Core Viewpoint - Kontoor Brands (KTB) has shown a significant price increase of 13.3% over the past four weeks, with a mean price target of $87.83 indicating a potential upside of 26.2% from the current price of $69.62 [1] Price Targets and Analyst Estimates - The mean estimate consists of six short-term price targets with a standard deviation of $9.22, suggesting variability in analyst predictions. The lowest estimate of $72 indicates a 3.4% increase, while the highest estimate suggests a 43.6% surge to $100 [2] - Analysts' price targets can often mislead investors, as empirical research shows that these targets rarely indicate actual stock price movements [7][10] - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Agreement - There is strong agreement among analysts regarding KTB's ability to report better earnings than previously predicted, which supports the expectation of an upside in the stock [4][11] - The Zacks Consensus Estimate for the current year has increased by 2.9% over the past month, with one estimate rising and no negative revisions [12] - KTB holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential for near-term upside [13]